TY  - GEN
AU  - Lorusso,V
AU  - Palmieri,G
AU  - Bianco,A R
AU  - Abate,G
AU  - Catalano,G
AU  - De Vita,F
AU  - Dammacco,F
AU  - Lauta,V M
AU  - Lucarelli,G
AU  - Polimeno,G
AU  - Mantovani,G
AU  - D'Aprile,M
AU  - Marzullo,F
AU  - De Lena,M
TI  - CEOP-B/VIMB vs. promace-CytaBOM in the treatment of intermediate or high grade non-Hodgkin's lymphoma: A randomised multicenter study of Southern Italy Cooperative Group
SN  - 1019-6439
PY  - 2000///0111
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Bleomycin
KW  - administration & dosage
KW  - Cyclophosphamide
KW  - Cytarabine
KW  - Doxorubicin
KW  - Epirubicin
KW  - Etoposide
KW  - Female
KW  - Humans
KW  - Lymphoma, Non-Hodgkin
KW  - drug therapy
KW  - Male
KW  - Methotrexate
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Prednisone
KW  - Survival Analysis
KW  - Treatment Outcome
KW  - Vincristine
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.3892/ijo.16.1.149
ER  -